A smoke-free home intervention in permanent supportive housing for formerly homeless adults
Assistant Professor, in the Division of General Internal Medicine/Zuckerberg San Francisco General Hospital, University of California at San Francisco
I am a practicing general internist and a researcher in tobacco control with a focus on populations experiencing homelessness. My research program aims to reduce the burden of tobacco use in vulnerable populations, particularly among those experiencing homelessness, through affecting change at the individual, health systems, community, and policy levels. I use a variety of methodologies, including descriptive epidemiology using national longitudinal and cross-sectional data, policy analysis, qualitative and mixed methods research, and implementation sciences. My work has included both community based participatory research to examine factors associated with high rates of tobacco use among vulnerable populations and implementation research within settings that serve these populations to improve access to smoke-free policies and cessation services.
1.Describe two ways that tobacco use impacts homeless adults
2.Discuss all of the results of a pilot study of a smoke-free home intervention in supportive housing
3.Discuss one other promising strategy to engage with people experiencing homelessness around smoking cessation
CME/CEU registration has closed for this live activity. The recorded version of the webinar will be available for credit in May.
ACCREDITATION FOR RESPIRATORY THERAPISTS
For CRCE certificates, email Aria Yow at [email protected] with your full name, credentials, AARC # and state of residence. You will receive your certificate within one week's time.
This program has been approved for a maximum of 1.0 contact hour Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd. Suite 100 Irving TX 75063. Course # 182929000.
Certificates of Attendance
Click here to generate a certificate of attendance for participating on this webinar.
The University of California, San Francisco (UCSF) School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
UCSF designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the webinar activity.
Advance Practice Registered Nurses and Registered Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 CreditTM issued by organizations accredited by the ACCME.
Physician Assistants: The National Commission on Certification of Physician Assistants (NCCPA) states that the AMA PRA Category 1 CreditTM are acceptable for continuing medical education requirements for recertification.
California Pharmacists: The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA category 1 CreditTM. If you are a pharmacist in another state, you should check with your state board for approval of this credit.
California Behavioral Science Professionals: University of California, San Francisco School of Medicine (UCSF) is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for behavioral health providers. UCSF maintains responsibility for this program/course and its content.
Course meets the qualifications for 1.0 hour of continuing education credit for LMFTs, LCSWs, LPCCs, and/or LEPs as required by the California Board of Behavioral Sciences. Provider # 64239.
This UCSF CME activity was planned and developed to uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.
The following speakers, moderators and planning committee members have disclosed they have no financial interest/arrangement or affiliation with any commercial companies who have provided products or services relating to their presentation(s) or commercial support for this continuing medical education activity:
Christine Cheng, Brian Clark, Jennifer Lucero, MA, MS, Jennifer Matekuare, Ma Krisanta Pamatmat, MPH, Jessica Safier, MA, Catherine Saucedo, Steven A. Schroeder, MD, Maya Vijayaraghavan, MD, MAS, and Aria Yow, MA
Here are resources used by Dr. Vijayaraghavan in her pilot study: